Arkolith/Insider Trading/EBS/Form 4

Harsanyi Zsolt

Chairman, DirectorEmergent BioSolutions Inc. (EBS) · full profile →Form 4 · filed May 2, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 30, 2025Grant(A)34K—$0124K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 30, 2025Grant(A)16K—$042K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001367644-25-000105) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML